- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02712086
Controlled Trial Evaluating the Efficacy of Protein Supplementation in the Short Term After Bariatric Surgery (PROTISLEEVE)
Randomized Controlled Trial Prospective Single-center Open Evaluating the Efficacy of Supplementation (Adapted to the Post-operative Period) Current Protein After Bariatric Surgery Like Sleeve Gastrectomy
The main objective will be to evaluate the effect at 5 weeks of nutritional management associated with protein supplementation (adapted to the post-operative period) on the maintenance of lean body mass at the whole body in obese patients after a sleeve gastrectomy.
Secondary objectives will assess protein intake, food safety, the effect of protein supplementation on body fat in the entire body and the metabolic rate and the impact on quality of life and post-operative joint pain.
Study Overview
Detailed Description
The main objective will be to evaluate the effect at 5 weeks of nutritional management associated with protein supplementation (adapted to the post-operative period) on the maintenance of lean body mass at the whole body in obese patients after a sleeve gastrectomy.
Secondary objectives will assess protein intake, food safety, the effect of protein supplementation on body fat in the entire body and the metabolic rate and the impact on quality of life and post-operative joint pain.
There is still no study evaluating the protein supplementation adapted patients after sleeve gastrectomy on maintaining lean body mass.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34295
- UHMontpellier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- surgical management of sleeve gastrectomy kind
Exclusion Criteria:
- food allergies
- Weight> 135 kg (maximum weight supported by the DXA)
- orthopedic prosthesis (hip, knee ...) that would make it impossible to interpret the measurement of DXA
- History of bariatric surgery: adjustable gastric banding, vertical banded gastrectomy ...
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: usual dietary management
Control group: usual dietary management Following the intervention, the stomach of patients underwent many changes
|
|
Experimental: care of with usual dietary protein supplementation
Intervention group: Usual dietary management with protein supplementation (30g) in addition to the usual inputs
|
Protein supplementation : Protein intake of 30 grams of protein in addition to the usual inputs (to the recommended amounts of 60 to 120 g per day), upon the resumption of oral intake until the fifth week after sleeve gastrectomy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in lean mass (kg) will be assessed at the level of whole-body dual-energy X-ray absorptiometry (DXA)
Time Frame: up to 1 month
|
up to 1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
food diary
Time Frame: 5 weeks after the hospital discharge
|
The actual protein intake will be assessed using a food diary over 5 weeks completed by the patient
|
5 weeks after the hospital discharge
|
change rate IGF1, IGFBP3
Time Frame: up to 1 month
|
change rate IGF1, IGFBP3 between hospitalization and 1 month of hospital discharge
|
up to 1 month
|
the quality of life
Time Frame: up to 1 month
|
The evolution of the quality of life will be assessed through a specific scale, Baros score.
|
up to 1 month
|
the quality of life
Time Frame: up to 5 years
|
The evolution of the quality of life will be assessed through a specific scale, Baros score.
|
up to 5 years
|
change rate IGF1, IGFBP3
Time Frame: up to 5 years
|
change rate IGF1, IGFBP3 between hospitalization and 5 years follow up
|
up to 5 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: David NOCCA, University Hospital, Montpellier
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- RECHMPL15_0173
- UF 9590 (Other Identifier: Montpellier University Hospital)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on protein supplementation
-
Seoul St. Mary's HospitalNot yet recruitingProtein MalnutritionKorea, Republic of
-
University of Alabama at BirminghamChildren's Health System, AlabamaActive, not recruitingPremature InfantUnited States
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Hospital Clinic of BarcelonaInstitut Nacional d'Educacio Fisica de Catalunya; Garmin InternationalCompletedBariatric Surgery Candidate | Sarcopenic Obesity | Nutritional Deficiency | Protein IntoleranceSpain
-
Centre Hospitalier de PAUNot yet recruiting
-
The University of Texas Health Science Center at...Completed
-
University of PadovaCompleted
-
Maastricht University Medical CenterCompletedOsteo Arthritis Knee | Protein MetabolismNetherlands
-
KU LeuvenCompletedKetosis | Protein Intake | Muscle Wasting | Caloric RestrictionBelgium
-
University of AarhusCompleted